ADIL - ADIAL PHARMACEUTICALS, INC.

📈 Is growth accelerating? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Dec 31, 2016 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
EPS Growth YoY (%)	-6150.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-335.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	82.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	78.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	69.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	84.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-8743.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	67.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	-1890.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	73.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-883.3% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	—	-889.3% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	9.2% Fair ↓ Fair Declining Year-over-year change in net income	9.3% Fair ↓ Fair Declining Year-over-year change in net income	3.6% Caution ↓ Caution Declining Year-over-year change in net income	65.6% Excellent ↑ Excellent Improving Year-over-year change in net income	65.6% Excellent ↑ Excellent Improving Year-over-year change in net income	65.6% Excellent ↑ Excellent Improving Year-over-year change in net income	-7.8% Weak ↑ Weak Improving Year-over-year change in net income	-122.9% Weak ↓ Weak Declining Year-over-year change in net income	-122.9% Weak ↓ Weak Declining Year-over-year change in net income	-122.9% Weak ↓ Weak Declining Year-over-year change in net income	33.0% Excellent ↑ Excellent Improving Year-over-year change in net income	0.1% Caution ↓ Caution Declining Year-over-year change in net income	0.1% Caution ↓ Caution Declining Year-over-year change in net income	0.1% Caution ↓ Caution Declining Year-over-year change in net income	50.8% Excellent ↑ Excellent Improving Year-over-year change in net income	32.7% Excellent ↑ Excellent Improving Year-over-year change in net income	34.5% Excellent ↑ Excellent Improving Year-over-year change in net income	39.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-68.1% Weak ↑ Weak Improving Year-over-year change in net income	-29.4% Weak ↑ Weak Improving Year-over-year change in net income	-145.2% Weak ↓ Weak Declining Year-over-year change in net income	-112.3% Weak ↓ Weak Declining Year-over-year change in net income	-68.5% Weak ↓ Weak Declining Year-over-year change in net income	-94.4% Weak ↓ Weak Declining Year-over-year change in net income	15.1% Good ↑ Good Improving Year-over-year change in net income	15.1% Good ↑ Good Improving Year-over-year change in net income	-62.2% Weak ↑ Weak Improving Year-over-year change in net income	79.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-19.1% Weak ↑ Weak Improving Year-over-year change in net income	-607.9% Weak ↑ Weak Improving Year-over-year change in net income	-214.2% Weak ↑ Weak Improving Year-over-year change in net income	-2699.1% Weak Weak Year-over-year change in net income	-578.2% Weak Weak Year-over-year change in net income	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Dec 31, 2016 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
FCF / Net Income (x)	3.15x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.80x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.66x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.71x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.70x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.25x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.64x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.79x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.61x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.86x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.41x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.59x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.75x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.80x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.64x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.87x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	0.57x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.30x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.47x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Dec 31, 2016 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Return on Invested Capital (%)	107.1% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-42.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-28.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-30.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-26.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-84.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-37.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-29.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-42.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-23.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-34.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-45.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-35.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-160.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-62.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-46.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-38.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-22.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-134.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-44.6% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-72.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-68.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-68.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-37.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-16.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-32.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-23.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-17.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-15.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-19.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-61.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	106.4% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	20.5% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	25.5% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—	—
Return on Capital (%) (%)	-178.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-38.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-28.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-31.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-27.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-65.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-38.5% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-32.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-46.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-37.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-47.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-39.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-74.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-45.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-41.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-35.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-21.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-80.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-38.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-54.6% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-56.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-63.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-40.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-19.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-38.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-27.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-18.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-20.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-18.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-23.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-72.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-930.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-931.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	5.3% Caution ↑ Caution Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-65%)	-54.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-463%)	-37.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-352%)	-49.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-430%)	-39.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-366%)	-104.8% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-799%)	-50.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-439%)	-110.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-834%)	-151.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1110%)	-105.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-805%)	-47.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-414%)	-124.2% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-928%)	-87.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-684%)	-201.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1445%)	-87.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-683%)	-53.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-458%)	-36.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-343%)	-27.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-281%)	-166.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1208%)	-60.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-500%)	-92.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-713%)	-86.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-674%)	-87.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-680%)	-47.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-414%)	-20.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-237%)	-41.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-373%)	-28.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-292%)	-19.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-231%)	-21.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-241%)	-22.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-252%)	-28.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-291%)	-166.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1208%)	138.6% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+824%)	29.0% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+93%)	40.5% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+170%)	—	—	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Dec 31, 2016 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-34.22x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	-10.58x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	—	—	$-5.88M	$-4.61M	$-5.91M	$-2.37M	$-3.75M	$-5.20M	$-3.29M	—	$-2.83M	$-315.88K	$-1.22M	$-2.31M	$-4.00M	$-5.75M	$-9.16M	$-12.69M	$-6.06M	$-7.18M	$-5.21M	$-5.64M	$-4.40M	$-7.37M	$-8.62M	$-4.95M	$-6.78M	$-8.53M	$-10.25M	$-11.39M	$-3.87M	$-4.82M	$-150.03K	$-53.97K	$-18.25K	$-40.35K	$-137.13K	$-87.99K	$-87.99K

📊 What does each share earn? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Dec 31, 2016 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Basic EPS, GAAP (USD)	$-11.25	$-1.48	$-11.48	$-0.08	$-0.18	$-0.34	$-65.44	$-0.38	$-0.59	$-2.19	$-0.74	$-1.18	$0.96	$-0.11	$-2.77	$-0.12	$-0.16	—	$-0.28	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-1.38	$-1.18	—	$-0.08	—	—	—	—	—	—	—	—	—	$-0.09	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$-14.61	$2.46	$4.75	$0.19	$0.26	$0.32	$15.72	$0.92	$1.00	—	$2.45	$1.92	$2.77	$0.05	$3.07	$0.20	$0.31	$0.45	$0.17	$0.35	$0.26	$0.33	$0.28	$0.50	$0.65	$0.52	$0.69	$0.85	$0.98	$1.15	$0.65	$0.75	$-0.36	—	$-0.31	—	—	—	—
Tangible Book Value per Share (USD)	$-14.62	$2.46	$4.75	$0.19	$0.26	$0.32	$15.70	$0.92	$1.00	—	$2.45	$1.92	$2.77	$0.04	$3.07	$0.19	$0.30	$0.44	$0.16	$0.35	$0.26	$0.32	$0.28	$0.50	$0.65	$0.52	$0.69	$0.85	$0.98	$1.15	$0.65	$0.75	$-0.36	—	$-0.31	—	—	—	—
Basic Weighted Avg Shares (shares)	4.62M	1.37M	—	22.17M	—	—	—	—	—	—	—	—	—	26.46M	—	25.72M	24.32M	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Dec 31, 2016 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Working Capital (USD)	$23.72M	$3.29M	$4.78M	$3.86M	$4.87M	$1.30M	$3.08M	$4.79M	$3.15M	—	$2.55M	$607.31K	$1.59M	$1.17M	$2.99M	$5.45M	$8.07M	$10.79M	$3.74M	$6.03M	$3.38M	$4.13M	$3.63M	$7.08M	$8.79M	$5.55M	$7.13M	$8.72M	$10.05M	$11.72M	$4.43M	$4.92M	$-1.30M	—	$-1.00M	—	—	—	—
Total Equity (USD)	$-38.38M	$3.72M	$5.28M	$4.51M	$5.59M	$2.13M	$4.07M	$5.88M	$4.28M	$6.12M	$4.08M	$2.34M	$3.32M	$1.44M	$3.28M	$5.41M	$7.96M	$10.71M	$3.51M	$7.20M	$4.83M	$5.62M	$3.99M	$7.09M	$8.79M	$5.55M	$7.14M	$8.73M	$10.06M	$11.73M	$4.44M	$4.93M	$-1.29M	$-1.31M	$-997.55K	—	—	$-103.49K	$-103.49K

📋 What is driving earnings? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Mar 31, 2018 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗	Q3 FY2017 Sep 30, 2017 10-Q ↗	Q2 FY2017 Jun 30, 2017 10-Q ↗	Q1 FY2017 Dec 31, 2016 10-Q ↗	Q4 FY2016 Dec 31, 2016 10-K ↗
Net Income, GAAP (USD)	$-2.02M	$-2.02M	$-2.00M	$-2.23M	$-2.23M	$-2.23M	$-2.07M	$-6.48M	$-6.48M	$-6.48M	$-1.92M	$-2.91M	$-2.91M	$-2.91M	$-2.87M	$-2.91M	$-2.91M	$-2.91M	$-5.83M	$-4.32M	$-4.44M	$-4.83M	$-3.47M	$-3.34M	$-1.81M	$-2.28M	$-2.06M	$-1.72M	$-2.13M	$-2.68M	$-1.27M	$-8.19M	$-1.79M	$-378.95K	$-403.99K	$-292.63K	$-264.27K	—	—
Operating Cash Flow (USD)	$-6.36M	$-1.61M	$-1.32M	$-1.83M	—	$-1.59M	$-1.45M	—	—	$-1.63M	$-1.22M	—	—	$-2.30M	$-1.75M	—	—	$-2.50M	$-2.37M	—	—	$-2.84M	$-2.61M	—	—	$-1.83M	$-1.75M	—	—	$-1.72M	$-1.10M	—	—	$-214.28K	$-122.10K	$-136.78K	—	—	—

ADIAL PHARMACEUTICALS, INC.

Analytical Summary

39-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare ADIL with peers